Can somatic BRCA2 status solve a case of olaparib monotherapy resistance? | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article info

other Versions

You are currently viewing an earlier version of this article (November 03, 2019).
View the most recent version of this article

Case studies

Can somatic BRCA2 status solve a case of olaparib monotherapy resistance?

Free

Authors

Antonella Pietragalla Presenter Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy PubMed articles Google scholar articles
Angelo Minucci Discussants Molecular and Genomic Diagnostics Laboratory, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy PubMed articles Google scholar articles
Claudia Marchetti Discussants Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy PubMed articles Google scholar articles
Giovanni Scambia Discussants Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyUniversita Cattolica del Sacro Cuore Facolta di Medicina e Chirurgia, Roma, Italy PubMed articles Google scholar articles
Anna Fagotti Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyUniversita Cattolica del Sacro Cuore Facolta di Medicina e Chirurgia, Roma, Italy PubMed articles Google scholar articles

Correspondence to Anna Fagotti, Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome 00168, Italy; annafagotti70{at}gmail.com

Citation

Pietragalla A, Minucci A, Marchetti C, et al

Can somatic BRCA2 status solve a case of olaparib monotherapy resistance?

International Journal of Gynecologic Cancer Published Online First: 19 September 2019. doi: 10.1136/ijgc-2019-000757

Publication history

Accepted August 23, 2019
First published September 19, 2019.

Article Versions

You are currently viewing a Previous version of this article (3 November 2019).
View the most recent version of this article

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.